Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Frequency of Comorbidities and Their Association with Clinical Disability and Relapse in Multiple Sclerosis.
[Optical coherence tomography in multiple sclerosis].
MP2RAGE Multiple Sclerosis Magnetic Resonance Imaging at 3 T.
Detecting cortical lesions in multiple sclerosis at 7 T using white matter signal attenuation.
Pharmacological protection of CNS white matter during anoxia: actions of phenytoin, carbamazepine and diazepam.
Alemtuzumab as rescue therapy in a cohort of 16 aggressive multiple sclerosis patients previously treated by Mitoxantrone: an observational study.
Imaging Microglial/Macrophage Activation in Spinal Cords of Experimental Autoimmune Encephalomyelitis Rats by Positron Emission Tomography Using the Mitochondrial 18 kDa Translocator Protein Radioligand [18F]DPA-714.
Physiopathology of symptoms and signs in multiple sclerosis.
Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis.
Complementary and alternative medicine in multiple sclerosis.
Central motor conduction time may predict response to fampridine in patients with multiple sclerosis.
Vitamin A and systemic inflammation as protective factors in multiple sclerosis.
Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies.
The mammalian Na+/H+ exchanger gene family--initial structure/function studies.
Minocycline treatment for rheumatoid arthritis: an open dose finding study.
FDA approves Ampyra to improve walking in adults with multiple sclerosis
Recombinant T-Cell Receptor Ligand (RTL) for Treatment of Multiple Sclerosis: A Double-Blind, Placebo-Controlled, Phase 1, Dose-Escalation Study.
Tacrolimus potently inhibits human osteoclastogenesis induced by IL-17 from human monocytes alone and suppresses human Th17 differentiation.
American Academy of Neurology Annual Meeting
Natalizumab exerts direct signaling capacity and supports a pro-inflammatory phenotype in some patients with multiple sclerosis.
UPDATE 2-FDA panel supports approval of Sanofi's MS drug Lemtrada
Neuromyelitis Optica Following Human Papillomavirus Vaccination.
MRI in multiple sclerosis: a review of the current literature.
Sodium accumulation is associated with disability and a progressive course in multiple sclerosis.
Multiple sclerosis and oligodendroglioma: an exceptional association.

Pages